Clues to catastrophic telomere loss in mammals from yeast telomere rapid deletion

Nature Reviews Genetics

Volumn 4, Issue 11, 2003, Pages 916-923

  Lustig, Arthur J ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; APOPTOSIS; ATAXIA TELANGIECTASIA; CARCINOGENESIS; CELL IMMORTALIZATION; EUKARYOTE; GENE DELETION; HUMAN; HUMAN CELL; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SENESCENCE; TELOMERE; YEAST;

ANIMALS; EVOLUTION; MAMMALS; NEOPLASMS; SEQUENCE DELETION; TELOMERE; YEASTS;

ANIMALIA; EUKARYOTA; MAMMALIA; MURINAE; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0242354121     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1207     Document Type: Review

References (69)

1. Greider, C. W. Telomere length regulation. Annu. Rev. Biochem. 65, 337-365 (1996).
2. Diede, S. J. & Gottschling, D. E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases α and δ. Cell 99, 723-733 (1999).
3. Qi, H. & Zakian, V. A. The Saccharomyces telomere-binding protein Cdc13p Interacts with both the catalytic subunit of DNA polymerase α and the telomerase-associated E1 protein. Genes Dev. 14, 1777-1788 (2000).
4. Greider, C. W. Telomerase Biochemistry and Regulation (Cold Spring Harbor Lab., Plainview, New York. 1995).
5. Marcand, S., Brevet, V. & Gilson, E. Progressive cis-inhibition of telomerase upon telomere elongaton. EMBO J. 18, 3509-3519 (1999).
6. Chan, S. W., Chang, J., Prescott, J. & Blackburn, E. H. Altering telomere structure allows telomerase to act in yeast lacking ATM kinases. Curr. Biol. 11, 1240-1250 (2001).
7. Ancelin, K. et al. Targeting assay to study the cis functions of human telomerase proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol. Cell Biol. 22, 3474-3487 (2002).
8. Loayza, D. & de Lange, T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 423, 1013-1018 (2003).
9. Colgin, L. M., Baran, K., Baumann, P., Cech, T. R. & Reddel, R. R. Human POT1 facilitates telomere elongation by telomerase. Curr. Biol. 13, 942-946 (2003).
10. Smogorzewska, A. & de Lange, T. Different telomere damage signalling pathways in human and mouse cells. EMBO J. 21, 4336-4348 (2002).
11. Kyrion, G., Boakye, K. A. & Lustig, A. J. C-terminal truncation of RAP1 results in the deregulation of telomere size, stability, and function in Saccharomyces cerivisiae. Mol. Cell. Biol. 12, 5159-5173 (1992).
12. Li, B. & Lustig, A. J. A novel mechanism for telomere size control in Saccharomyces cerevisiae. Genes Dev. 10, 1310-1326 (1996).
13. Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W. & Harley, C. B. Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951-960 (1992).
14. Conrad, M. N., Dominguez, A. M. & Dresser, M. E. Ndj1p, a meiotic telomere protein required for normal chromosome synapsis and segregation in yeast. Science 278, 1252-1255 (1997).
15. Goldman, A. S. & Lichten, M. Restriction of ectopic recombination by interhomolog interactions during Saccharomyces cerevisiae meiosis. Proc. Natl. Acad. Sci. USA 97, 9537-9542 (2000).
16. Cooper, J. P., Watanabe, Y. & Nurse, P. Fission yeast Taz1 protein is required for meiotic telomere clustering and recombination. Nature 392, 828-831 (1998).
17. Bucholc, M., Park, Y. & Lustig, A. J. Intrachromatid excision of telomeric DNA as a mechanism for telomere size control in Saccharomyces cerevisiae. Mol. Cell Biol. 21, 6559-6573 (2001).
18. Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999).
19. Munoz-Jordan, J. L., Cross, G. A., de Lange, T. & Griffith, J. D. t-loops at trypanosome telomeres. EMBO J. 20, 579-588 (2001).
20. Lindstrom, U. M. et al. Artificial human telomeres from DNA nanocircle templates. Proc. Natl. Acad. Sci. USA 99, 15953-15958 (2002).
21. Aguilera, A. & Klein, H. L. Genetic and molecular analysis of recombination events in Saccharomyces cerevisiae occurring in the presence of the hyper-recombination mutation hpr1. Genetics 122, 503-517 (1989).
22. Usui, T., Ogawa, H. & Petrini, J. H. A DNA damage response pathway controlled by Tel1 and the Mre11 complex. Mol. Cell 7, 1255-1266 (2001).
23. Lundblad, V. Telomere maintenance without telomerase, Oncogene 21, 522-531 (2002).
24. Zhu, X. D., Kuster, B., Mann, M., Petrini, J. H. & de Lange, T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nature Genet. 25, 347-352 (2000).
25. Polotnianka, R. M., Li, J. & Lustig, A. J. The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr. Biol. 8, 831-834 (1998).
26. Chen, Q., Ijpma, A. & Grelder, C. W. Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol. Cell Biol. 21, 1819-1827 (2001).
27. Teng, S., Chang, J., McCowan, B. & Zakian, V. A. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, rif-inhibited recombinational process. Mol. Cell. 6, 947-952 (2000).
28. Teng, S. C. & Zaklan, V. A. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell Biol. 19, 8083-8093 (1999).
29. Tsai, Y. L., Tseng, S. F., Chang, S. H., Lin, C. C. & Teng, S. C. Involvement of replicative polymerases, Tel1p, Mec1p, Cdc13p, and the Ku complex in telomere-telomere recombination. Cell 22, 5679-5687 (2002).
30. Neumann, A. A. & Reddel, R. R. Telomere maintenance and cancer - look, no telomerase. Nature Rev. Cancer 2, 879-884 (2002).
31. Enomoto, S., Glowczewski, L. & Berman, J. MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae. Mol. Biol. Cell 13, 2626-2638 (2002).
32. Ijpma, A. & Greider, C. W. Short telomeres induce a DNA damage response In Saccharomyces cerevisiae. Mol. Biol. Cell 14, 987-1001 (2003).
33. Singh, S. M., Steinberg-Neifach, O., Mian, I. S. & Lue, N. F. Analysis of telomerase in Candida albicans: potential role in telomere end protection. Eukaryot. Cell 1, 967-977 (2002).
34. Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91,25-34 (1997).
35. Murnane, J. P., Sabatier, L., Marder, B. A. & Morgan, W. F. Telomere dynamics in an Immortal human cell line. EMBO J. 13, 4953-4962 (1994).
36. Martens, U. M., Chavez, E. A., Poon, S. S., Schmoor, C. & Lansdorp, P. M. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res. 258, 291-299 (2000).
37. Oexle, K. Telomere length distribution and Southern blot analysis. J. Theor. Biol. 190, 369-377 (1998).
38. Rubelj, I. & Vondracek, Z. Stochastic mechanism of cellular aging - abrupt telomere shortening as a model for stochastic nature of cellular aging. J. Theor. Biol. 197, 425-438 (1999).
39. Baird, D., Rowson, J., Wynford-Thomas, D. & Kipling, D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nature Genet. 33, 203-207 (2003).
40. Perrem, K. et al. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18, 3383-3390 (1999).
41. Ramirez, R. et al. Massive telomere loss is an early event of DNA damage-induced apoptosis. J. Biol. Chem. 278, 836-842 (2003).
42. Hande, M. P., Balajee, A. S., Tchirkov, A., Wynshaw-Boris, A. & Lansdorp, P. M. Extra-chromosomal telomeric DNA in cells from Atm(-/-) mice and patients with ataxia-telanglectasia. Hum. Mol. Genet. 10, 519-528 (2001).
43. Ogino, H. et al. Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun. 248, 223-227 (1998).
44. Regev, A., Cohen, S., Cohen, E., Bar-Am, I. & Lavi, S. Telomeric repeats on small polydisperse circular DNA (spcDNA) and genomic Instability. Oncogene 17, 3455-3461 (1998).
45. Stansel, R. M., de Lange, T. & Griffith, J. D. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J. 20, 5532-5540 (2001).
46. de Lange, T. Protection of mammalian telomeres. Oncogene 21, 532-540 (2002).
47. Broccoli, D., Smogorzewska, A., Chong, L. & de Lange, T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nature Genet. 17, 231-235 (1997).
48. Li, B., Oestreich, S. & de Lange, T. Identification of human Rap1: implications for telomere evolution. Cell 101, 471-483 (2000).
49. Li, B. & de Lange, T. RAP1 affects the length and heterogeneity of human telomeres. Mol. Biol. Cell (in the press).
50. Wu, G., Jiang, X., Lee, W. H. & Chen, P. L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63, 2589-2595 (2003).
51. Lombard, D. B. & Guarente, L. Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and melotic telomeres. Cancer Res. 60, 2331-2334 (2000).
52. Yeager, T. R. et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179 (1999).
53. Bender, C. F. et al. Cancer predisposition and hematopoietic failure in Rad50(SIS) mice. Genes Dev. 16, 2237-2251 (2002).
54. Tauchj, H., Matsuura, S., Kobayashi, J., Sakamoto, S. & Komatsu, K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21, 8967-8980 (2002).
55. Zhang, X. et al. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells. Cancer Res. 63, 760-765 (2003).
56. Stansel, R. M., Subramanian, D. & Griffith, J. D. p53 binds telomeric single strand overhangs and t-loop junctions in vitro. J. Biol. Chem. 277, 11625-11628 (2002).
57. Evans, S. K. & Lundblad, V. Est1 and Cric13 as comediators of telomerase access. Science 286, 117-120 (1999).
58. Taggart, A. K., Teng, S. C. & Zaklan, V. A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science 297, 1023-1026 (2002).
59. Relchenbach, P. et al. A human homolog of yeast est1 associates with telomerase and uncaps chromosome ends when overexpressed. Curr. Biol. 13. 568-574 (2003).
60. Snow, B. E. et al. Functional conservation of the telomerase protein est1p in humans. Curr. Biol. 13, 698-704 (2003).
61. d'Adda di Fagagna, F. et al. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11, 1192-1196 (2001).
62. Hande, M. P., Samper, E., Lansdorp, P. & Blasco, M. A. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589-601 (1999).
63. Espejel, S. et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21, 2207-2219 (2002).
64. Chan, S. W-L. & Blackburn, E. H. Telomerase and ATM/Tel1p protect telomeres from non-homologous end-joining. Mol. Cell 11, 1379-1387 (2003).
65. Luderus, M. E. et al. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex. J. Cell Biol. 135, 867-881 (1996).
66. Williams, B. R. et al. A murine model of Nijmegen breakage syndrome. Curr. Biol. 12, 648-653 (2002).
67. Robertson, J. D. et al. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br. J. Haematol. 109, 272-279 (2000).
68. Zeichner, S. L. et al. Rapid telomere shortening in children. Blood 93, 2824-2830 (1999).
69. McEachern, M. J. & Iyer, S. Short telomeres in yeast are highly recombinogenic. Mol. Cell 7, 695-704 (2001).